Hims & Hers is a large biotech.
Deals (12mo)
2
Active Trials
0
Top Modality
N/A
Focus Area
N/A
Use Solidus to benchmark upfront payments, milestones, and royalties — powered by data from 3,500+ real biopharma transactions.
Hims & Hers is a large biotech company that has been actively engaged in licensing transactions across the biopharma landscape.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Hims & Hers and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Hims & Hers's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.
© 2026 Ambrosia Ventures. All rights reserved.
Benchmarks powered by 1,600+ real biopharma licensing deals